Loading clinical trials...
Loading clinical trials...
The purpose of this study is to characterize the safety and tolerability of KW-3902IV and measure its effect on renal function.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Collaborators
NCT02769975 · Adrenal Insufficiency, Growth Disorder, and more
NCT07262333 · Renal Insufficiency Chronic
NCT00181259 · Heart Failure, Congestive
NCT01524276 · Cardiac Rhythm Disorders, Urological Disorders, and more
NCT06001827 · Chronic Kidney Diseases, End Stage Renal Disease, and more
San Diego, California
Baltimore, Maryland
Ayer, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions